Company Filing History:
Years Active: 2022
Title: Hui Yang: Innovator in Anti-Epileptic Drug Development
Introduction
Hui Yang is a prominent inventor based in Hunan, China. He has made significant contributions to the field of pharmacology, particularly in the development of anti-epileptic drugs. His innovative work focuses on the use of specific inhibitors to enhance treatment options for epilepsy.
Latest Patents
Hui Yang holds a patent for the "Use of I-BRD9 or derivatives thereof in preparing anti-epileptic drugs." This patent outlines methods for utilizing bromodomain-containing protein 9 inhibitor (I-BRD9) or its derivatives in the preparation of anti-epileptic medications. The findings indicate that I-BRD9 has substantial effects on anticonvulsion, prolonging convulsion latency, and reducing seizure levels. This innovation holds promise for improving the efficacy of anti-epileptic drug preparations.
Career Highlights
Hui Yang is affiliated with the University of South China, where he continues to advance his research in pharmacology. His work has garnered attention for its potential impact on the treatment of epilepsy, showcasing his dedication to improving patient outcomes through innovative drug development.
Collaborations
Hui Yang collaborates with notable colleagues, including Wenyu Cao and Yang Xu. Their combined expertise contributes to the advancement of research in the field of anti-epileptic drug development.
Conclusion
Hui Yang's contributions to the field of anti-epileptic drug development highlight his role as an innovator in pharmacology. His patent on the use of I-BRD9 demonstrates the potential for new treatment options for epilepsy, showcasing the importance of continued research and innovation in this critical area of healthcare.